BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26851044)

  • 1. Impact of Body Weight Loss on Recurrence After Curative Gastrectomy for Gastric Cancer.
    Kubo H; Komatsu S; Ichikawa D; Kawaguchi T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    Anticancer Res; 2016 Feb; 36(2):807-13. PubMed ID: 26851044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival impact of postoperative body mass index in gastric cancer patients undergoing gastrectomy.
    Lee HH; Park JM; Song KY; Choi MG; Park CH
    Eur J Cancer; 2016 Jan; 52():129-37. PubMed ID: 26686912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer.
    Aoyama T; Sato T; Maezawa Y; Kano K; Hayashi T; Yamada T; Yukawa N; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Int J Clin Oncol; 2017 Jun; 22(3):476-483. PubMed ID: 28176023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Low Weight Affects Long-term Outcomes Following Curative Gastrectomy for Gastric Cancer.
    Komatsu S; Kosuga T; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    Anticancer Res; 2018 Sep; 38(9):5331-5337. PubMed ID: 30194185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer.
    Lee SE; Lee JH; Ryu KW; Nam B; Kim CG; Park SR; Kook MC; Kim YW
    Hepatogastroenterology; 2012; 59(114):430-5. PubMed ID: 22353511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer.
    Aoyama T; Yoshikawa T; Shirai J; Hayashi T; Yamada T; Tsuchida K; Hasegawa S; Cho H; Yukawa N; Oshima T; Rino Y; Masuda M; Tsuburaya A
    Ann Surg Oncol; 2013 Jun; 20(6):2000-6. PubMed ID: 23242818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of post-operative surveillance on the prognosis after curative surgery for gastric cancer.
    Lee JH; Lim JK; Kim MG; Kwon SJ
    Hepatogastroenterology; 2014 Oct; 61(135):2123-32. PubMed ID: 25713919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer.
    Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
    Ann Surg Oncol; 2013 May; 20(5):1575-83. PubMed ID: 23076557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer.
    Climent M; Hidalgo N; Vidal Ó; Puig S; Iglesias M; Cuatrecasas M; Ramón JM; García-Albéniz X; Grande L; Pera M
    Eur J Surg Oncol; 2016 Jan; 42(1):132-9. PubMed ID: 26385054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of enteral nutrition enriched with eicosapentaenoic acid on body weight loss and compliance with S-1 adjuvant chemotherapy after gastric cancer surgery].
    Aoyama T; Hayashi T; Fujikawa H; Ogata T; Cho H; Wada H; Kitani Y; Yukawa N; Oshima T; Rino Y; Ozawa Y; Masuda M; Yoshikawa T
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2289-91. PubMed ID: 24394088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.
    Bilici A; Salman T; Oven Ustaalioglu BB; Unek T; Seker M; Aliustaoglu M; Gezen C; Unek T; Yavuzer D; Unlu M; Gumus M; Yilmaz U
    J Surg Res; 2013 Mar; 180(1):e1-9. PubMed ID: 22520575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for severe weight loss at 1 month after gastrectomy for gastric cancer.
    Segami K; Aoyama T; Kano K; Maezawa Y; Nakajima T; Ikeda K; Sato T; Fujikawa H; Hayashi T; Yamada T; Oshima T; Yukawa N; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Asian J Surg; 2018 Jul; 41(4):349-355. PubMed ID: 28545783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and survival in patients with gastric stump cancer.
    Huang H; Wang W; Chen Z; Jin JJ; Long ZW; Cai H; Liu XW; Zhou Y; Wang YN
    World J Gastroenterol; 2015 Feb; 21(6):1865-71. PubMed ID: 25684953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma.
    Oh SJ; Hyung WJ; Li C; Song J; Rha SY; Chung HC; Choi SH; Noh SH
    J Gastroenterol Hepatol; 2009 Mar; 24(3):475-9. PubMed ID: 19054266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.
    Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term and long-term risk factors in gastric cancer.
    Verlato G; Marrelli D; Accordini S; Bencivenga M; Di Leo A; Marchet A; Petrioli R; Zoppini G; Muggeo M; Roviello F; de Manzoni G
    World J Gastroenterol; 2015 Jun; 21(21):6434-43. PubMed ID: 26074682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
    Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
    Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
    Qiu JL; Deng MG; Li W; Zou RH; Li BK; Zheng Y; Lao XM; Zhou K; Yuan YF
    Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.